These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1564230)

  • 1. Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy.
    Doherty NE; Seelos KC; Suzuki J; Caputo GR; O'Sullivan M; Sobol SM; Cavero P; Chatterjee K; Parmley WW; Higgins CB
    J Am Coll Cardiol; 1992 May; 19(6):1294-302. PubMed ID: 1564230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of left ventricular diastolic function in dilated cardiomyopathy with cine magnetic resonance imaging: effect of an angiotensin converting enzyme inhibitor, benazepril.
    Fujita N; Hartiala J; O'Sullivan M; Steiman D; Chatterjee K; Parmley WW; Higgins CB
    Am Heart J; 1993 Jan; 125(1):171-8. PubMed ID: 8417514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simultaneous alterations in preload and afterload on measurements of left ventricular contractility in patients with dilated cardiomyopathy: comparisons of ejection phase, isovolumetric and end-systolic force-velocity indexes.
    Borow KM; Neumann A; Marcus RH; Sareli P; Lang RM
    J Am Coll Cardiol; 1992 Oct; 20(4):787-95. PubMed ID: 1527288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of benazepril on heart rate turbulence in patients with dilated cardiomyopathy.
    Zhong JH; Chen XP; Zeng CF; Yun ML; Yang XW; Chen YF; Yao Z
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):612-6. PubMed ID: 17581217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular unloading and improvement in left ventricular function after angiotensin converting enzyme inhibition with enalapril in patients with chronic congestive heart failure.
    Naganuma F; Kubota S; Hirahara N; Imai K; Kamiyama H; Iizuka T; Imai S; Murata K; Suzuki T
    Jpn Circ J; 1994 Jan; 58(1):34-42. PubMed ID: 8139090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin-converting enzyme inhibition.
    Volpe M; Rao MA; Cuocolo A; Russo R; Nappi A; Mele AF; Enea I; Trimarco B; Condorelli M
    Circulation; 1995 Nov; 92(9):2511-8. PubMed ID: 7586352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
    J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance.
    Buser PT; Auffermann W; Holt WW; Wagner S; Kircher B; Wolfe C; Higgins CB
    J Am Coll Cardiol; 1989 May; 13(6):1294-300. PubMed ID: 2703612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
    Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function.
    Benjelloun H; Cranney GB; Kirk KA; Blackwell GG; Lotan CS; Pohost GM
    Am J Cardiol; 1991 Jun; 67(16):1413-20. PubMed ID: 2042573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
    Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle.
    Semelka RC; Tomei E; Wagner S; Mayo J; Caputo G; O'Sullivan M; Parmley WW; Chatterjee K; Wolfe C; Higgins CB
    Am Heart J; 1990 Jun; 119(6):1367-73. PubMed ID: 2141222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
    Starling MR
    Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Stevenson LW; Bellil D; Grover-McKay M; Brunken RC; Schwaiger M; Tillisch JH; Schelbert HR
    Am J Cardiol; 1987 Sep; 60(8):654-8. PubMed ID: 3661430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hydralazine on pressure-volume and stress-volume relations in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Smucker ML; Sanford CF; Lipscomb KM
    Am J Cardiol; 1985 Oct; 56(10):690-5. PubMed ID: 4050708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.